Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Reddy's Laboratories' Board of Directors approved several key appointments at its May 12, 2026 meeting. The Board re-appointed Dr. K P Krishnan as Independent Director for a second 5-year term (January 2027 to January 2032) and appointed Mr. Srikanth Velamakanni (Co-Founder and CEO of Fractal, an AI company) as a new Independent Director for 5 years (July 2026 to June 2031). Additionally, the company appointed Deloitte Haskins & Sells, LLP as its new Statutory Auditors for a 5-year term, replacing the previous auditors. M/s Sagar & Associates was re-appointed as Cost Auditors for FY 2026-27. Mr. Sandeep Khandelwal, who heads the India subcontinent business (a USD 750 million operation), was elevated to Senior Management Personnel and inducted into the Management Council.
The appointment of Deloitte as statutory auditors represents a change in audit firm, which investors should monitor for any implications. The addition of two experienced Independent Directors, including a prominent AI technology leader, could bring fresh expertise to the board. Sandeep Khandelwal's elevation strengthens the senior leadership team ahead of potential succession planning.